Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 16, 2023

SELL
$1.66 - $3.67 $212,314 - $469,393
-127,900 Reduced 79.74%
32,500 $57,000
Q4 2022

Feb 14, 2023

SELL
$2.77 - $5.07 $132,406 - $242,346
-47,800 Reduced 22.96%
160,400 $503,000
Q3 2022

Nov 14, 2022

SELL
$4.27 - $6.39 $438,528 - $656,253
-102,700 Reduced 33.03%
208,200 $1.02 Million
Q2 2022

Aug 15, 2022

SELL
$3.28 - $6.21 $58,056 - $109,917
-17,700 Reduced 5.39%
310,900 $1.29 Million
Q1 2022

May 16, 2022

BUY
$5.23 - $7.82 $171,021 - $255,714
32,700 Added 11.05%
328,600 $1.91 Million
Q4 2021

Feb 14, 2022

SELL
$7.29 - $10.97 $826,686 - $1.24 Million
-113,400 Reduced 27.71%
295,900 $2.22 Million
Q3 2021

Nov 15, 2021

BUY
$9.01 - $12.01 $523,481 - $697,781
58,100 Added 16.54%
409,300 $3.69 Million
Q2 2021

Aug 11, 2021

BUY
$10.17 - $12.64 $249,165 - $309,680
24,500 Added 7.5%
351,200 $4.2 Million
Q1 2021

May 17, 2021

SELL
$10.88 - $17.05 $2.5 Million - $3.92 Million
-230,200 Reduced 41.34%
326,700 $4.09 Million
Q4 2020

Feb 16, 2021

SELL
$9.23 - $18.18 $422,734 - $832,644
-45,800 Reduced 7.6%
556,900 $8.69 Million
Q3 2020

Nov 16, 2020

BUY
$9.38 - $12.48 $1.19 Million - $1.59 Million
127,100 Added 26.72%
602,700 $5.7 Million
Q2 2020

Aug 14, 2020

BUY
$6.21 - $11.83 $817,236 - $1.56 Million
131,600 Added 38.26%
475,600 $4.26 Million
Q1 2020

May 15, 2020

BUY
$5.05 - $8.85 $467,630 - $819,510
92,600 Added 36.83%
344,000 $2.19 Million
Q4 2019

Feb 14, 2020

SELL
$8.03 - $11.7 $3.62 Million - $5.28 Million
-451,400 Reduced 64.23%
251,400 $2.1 Million
Q3 2019

Nov 14, 2019

SELL
$9.05 - $12.22 $186,430 - $251,732
-20,600 Reduced 2.85%
702,800 $6.36 Million
Q2 2019

Aug 14, 2019

SELL
$8.75 - $13.03 $4 Million - $5.95 Million
-456,700 Reduced 38.7%
723,400 $7.79 Million
Q1 2019

May 15, 2019

BUY
$7.72 - $12.81 $4.28 Million - $7.1 Million
554,300 Added 88.57%
1,180,100 $11.3 Million
Q4 2018

Feb 14, 2019

SELL
$9.51 - $16.6 $2.66 Million - $4.63 Million
-279,200 Reduced 30.85%
625,800 $7.18 Million
Q3 2018

Nov 14, 2018

BUY
$13.05 - $19.05 $2.48 Million - $3.62 Million
190,000 Added 26.57%
905,000 $15.3 Million
Q2 2018

Aug 14, 2018

BUY
$13.9 - $19.8 $4.14 Million - $5.9 Million
298,200 Added 71.55%
715,000 $10.2 Million
Q1 2018

May 15, 2018

SELL
$16.7 - $26.35 $1.14 Million - $1.79 Million
-68,100 Reduced 14.04%
416,800 $7.92 Million
Q4 2017

Feb 14, 2018

BUY
$11.6 - $17.35 $2.58 Million - $3.86 Million
222,600 Added 84.86%
484,900 $7.95 Million
Q3 2017

Nov 14, 2017

BUY
$8.4 - $15.0 $2.2 Million - $3.93 Million
262,300
262,300 $3.94 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $56.4M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.